ABPEPserver: a web application for documentation and analysis of substitutants

Abstract Background Cancer immunotherapy is implemented by identifying antigens that are presented on the cell surface of cancer cells and illicit T-cell response (Schumacher and Schreiber, Science 348:69–74, 2015; Waldman et al., Nat Rev Immunol 20:651–668, 2020; Zhang et al., Front Immunol 12:672,...

Full description

Bibliographic Details
Main Authors: Abhijeet Pataskar, Jasmine Montenegro Navarro, Reuven Agami
Format: Article
Language:English
Published: BMC 2023-06-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-023-10970-8
_version_ 1797811434486235136
author Abhijeet Pataskar
Jasmine Montenegro Navarro
Reuven Agami
author_facet Abhijeet Pataskar
Jasmine Montenegro Navarro
Reuven Agami
author_sort Abhijeet Pataskar
collection DOAJ
description Abstract Background Cancer immunotherapy is implemented by identifying antigens that are presented on the cell surface of cancer cells and illicit T-cell response (Schumacher and Schreiber, Science 348:69–74, 2015; Waldman et al., Nat Rev Immunol 20:651–668, 2020; Zhang et al., Front Immunol 12:672,356, 2021b). Classical candidates of such antigens are the peptides resulting from genetic alterations and are named “neoantigen" (Schumacher and Schreiber, Science 348:69–74, 2015). Neoantigens have been widely catalogued across several human cancer types (Tan et al., Database (Oxford) 2020;2020b; Vigneron et al., Cancer Immun 13:15, 2013; Yi et al., iScience 24:103,107, 2021; Zhang et al., BMC Bioinformatics 22:40, 2021a). Recently, a new class of inducible antigens has been identified, namely Substitutants, that are produced as a result of aberrant protein translation (Pataskar et al., Nature 603:721–727, 2022). Main Catalogues of Substitutant expression across human cancer types, their specificity and association to gene expression signatures remain elusive for the scientific community's access. As a solution, we present ABPEPserver, an online database and analytical platform that can visualize a large-scale tumour proteomics analysis of Substitutant expression across eight tumour types sourced from the CPTAC database (Edwards et al., J Proteome Res 14:2707–2713, 2015). Functionally, ABPEPserver offers the analysis of gene-association signatures of Substitutant peptides, a comparison of enrichment between tumour and tumour-adjacent normal tissues, and a list of peptides that serve as candidates for immunotherapy design. ABPEPserver will significantly enhance the exploration of aberrant protein production in human cancer, as exemplified in a case study. Conclusion ABPEPserver is designed on an R SHINY platform to catalogue Substitutant peptides in human cancer. The application is available at https://rhpc.nki.nl/sites/shiny/ABPEP/ . The code is available under GNU General public license from GitHub ( https://github.com/jasminesmn/ABPEPserver ).
first_indexed 2024-03-13T07:23:39Z
format Article
id doaj.art-c5a6a4a75bd54206b000c3841378bdf7
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-03-13T07:23:39Z
publishDate 2023-06-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-c5a6a4a75bd54206b000c3841378bdf72023-06-04T11:31:27ZengBMCBMC Cancer1471-24072023-06-012311710.1186/s12885-023-10970-8ABPEPserver: a web application for documentation and analysis of substitutantsAbhijeet Pataskar0Jasmine Montenegro Navarro1Reuven Agami2Division of Oncogenomics, Oncode Institute, The Netherlands Cancer InstituteDivision of Oncogenomics, Oncode Institute, The Netherlands Cancer InstituteDivision of Oncogenomics, Oncode Institute, The Netherlands Cancer InstituteAbstract Background Cancer immunotherapy is implemented by identifying antigens that are presented on the cell surface of cancer cells and illicit T-cell response (Schumacher and Schreiber, Science 348:69–74, 2015; Waldman et al., Nat Rev Immunol 20:651–668, 2020; Zhang et al., Front Immunol 12:672,356, 2021b). Classical candidates of such antigens are the peptides resulting from genetic alterations and are named “neoantigen" (Schumacher and Schreiber, Science 348:69–74, 2015). Neoantigens have been widely catalogued across several human cancer types (Tan et al., Database (Oxford) 2020;2020b; Vigneron et al., Cancer Immun 13:15, 2013; Yi et al., iScience 24:103,107, 2021; Zhang et al., BMC Bioinformatics 22:40, 2021a). Recently, a new class of inducible antigens has been identified, namely Substitutants, that are produced as a result of aberrant protein translation (Pataskar et al., Nature 603:721–727, 2022). Main Catalogues of Substitutant expression across human cancer types, their specificity and association to gene expression signatures remain elusive for the scientific community's access. As a solution, we present ABPEPserver, an online database and analytical platform that can visualize a large-scale tumour proteomics analysis of Substitutant expression across eight tumour types sourced from the CPTAC database (Edwards et al., J Proteome Res 14:2707–2713, 2015). Functionally, ABPEPserver offers the analysis of gene-association signatures of Substitutant peptides, a comparison of enrichment between tumour and tumour-adjacent normal tissues, and a list of peptides that serve as candidates for immunotherapy design. ABPEPserver will significantly enhance the exploration of aberrant protein production in human cancer, as exemplified in a case study. Conclusion ABPEPserver is designed on an R SHINY platform to catalogue Substitutant peptides in human cancer. The application is available at https://rhpc.nki.nl/sites/shiny/ABPEP/ . The code is available under GNU General public license from GitHub ( https://github.com/jasminesmn/ABPEPserver ).https://doi.org/10.1186/s12885-023-10970-8SubstitutantsCodon reassignmentTranslationCancerImmunotherapy
spellingShingle Abhijeet Pataskar
Jasmine Montenegro Navarro
Reuven Agami
ABPEPserver: a web application for documentation and analysis of substitutants
BMC Cancer
Substitutants
Codon reassignment
Translation
Cancer
Immunotherapy
title ABPEPserver: a web application for documentation and analysis of substitutants
title_full ABPEPserver: a web application for documentation and analysis of substitutants
title_fullStr ABPEPserver: a web application for documentation and analysis of substitutants
title_full_unstemmed ABPEPserver: a web application for documentation and analysis of substitutants
title_short ABPEPserver: a web application for documentation and analysis of substitutants
title_sort abpepserver a web application for documentation and analysis of substitutants
topic Substitutants
Codon reassignment
Translation
Cancer
Immunotherapy
url https://doi.org/10.1186/s12885-023-10970-8
work_keys_str_mv AT abhijeetpataskar abpepserverawebapplicationfordocumentationandanalysisofsubstitutants
AT jasminemontenegronavarro abpepserverawebapplicationfordocumentationandanalysisofsubstitutants
AT reuvenagami abpepserverawebapplicationfordocumentationandanalysisofsubstitutants